High Court Asked To Reject Appeal Of Post-Mensing Ruling
The plaintiff in a major First Circuit ruling over whether generic-drug companies can be targeted for design defect claims asked the U.S. Supreme Court on Wednesday to block Mutual Pharmaceutical Co.'s...To view the full article, register now.
Already a subscriber? Click here to view full article